By Emmanuel Enemchukwu with Hien X. T. Nguyen, Chenxi Liu, and Elizabeth Ren
Typical of REITs, the most compelling investment thesis for a Healthcare REIT like Medical Property Trust (MPW) has usually been the generous dividend payout. The generosity of its dividends not taken for granted, our valuation of MPW makes a case for underpricing. We are convinced that $17.20 per share – at the very least – is a more accurate reflection of the future prospects built into MPW’s fundamentals. At a current price of $12.66, this represents a whopping 36% upside.
Reality has played out rather differently for MPW. The stock price is back to where it was March when the bankruptcy proceedings of Adeptus – one of its biggest tenants – sent investors scampering. The entire Adeptus issue turned out to be overblown – further discussions later – but it also emblematized the challenges of the wider Medical REITs space. Nevertheless, we are convinced that an eventual appreciation is certain.
Hot Medical Stocks To Own Right Now: UNIVERSAL INSURANCE HOLDINGS INC(UVE)
- [By Jim Robertson]
Small cap Florida insurance stock Universal Insurance Holdings (NYSE: UVE) has taken a hit with shares downalmost 17%over the past week on predictions that Hurricane Irma would hit Florida albeit sharesrose 8.51%on Friday when it became clear that it would not be as catastrophic as feared:
Hot Medical Stocks To Own Right Now: Big 5 Sporting Goods Corporation(BGFV)
- [By Nicholas Rossolillo]
Dick’s Sporting Goods (NYSE:DKS) and Big 5 Sporting Goods (NASDAQ:BGFV) have both had a great 2016. As far as stock performance goes, Big 5 is the winner this year. But which company is in better shape for the new year?
Hot Medical Stocks To Own Right Now: Virtus Investment Partners Inc.(VRTS)
- [By Lisa Levin]
Shares of Virtus Investment Partners Inc (NASDAQ: VRTS) got a boost, shooting up 19 percent to $111.05 following Q3 results. Virtus Investment posted Q3 earnings of $1.64 per share on revenue of $82.3 million.
Hot Medical Stocks To Own Right Now: GTx Inc.(GTXI)
- [By Roberto Pedone]
One biopharmaceutical player that’s rapidly moving within range of triggering a major breakout trade is GTx (GTXI), which is dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition. This stock has been hammered by the bears so far in 2013, with shares off sharply by 53%.
If you look at the chart for GTx, you’ll notice that this stock recently gapped down sharply from over $4 to below $1.50 a share with heavy downside volume. Following that gap down, shares of GTXI have rebounded sharply and started to uptrend, with the stock moving higher from its low of $1.31 to its recent high of $1.96 a share. During that move, shares of GTXI have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GTXI within range of triggering a major breakout trade.
Traders should now look for long-biased trades in GTXI if it manages to break out above some near-term overhead resistance at $1.96 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.35 million shares. If that breakout triggers soon, then GTXI will set up to re-fill some of its previous gap down zone from August that started just above $4 a share. Some possible upside targets if GTXI gets into that gap with volume are $2.50 to $3 a share, or possibly even $3.50 a share.
Traders can look to buy GTXI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $1.50 a share. One can also buy GTXI off strength once it takes out $1.96 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.